In the following subsections, we discuss three peptide categories that are known to induce weight loss
Studies and adverse event reports have associated GLP-1 medications with an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss
The chart is based on dose timing and known pharmacokinetics, not a blood test, but it can help you connect side effects, hunger, and energy changes to where you are in your dosing cycle
It was investigated but did not become an approved obesity drug
Athletic Performance Active Test Athletic performance aids help trainers and coaches create personalised training and nutrition plans for elite athletes, integrating sports and dietary analysis to maximise fitness, support weight management, and achieve peak conditioning
Muscle is slower to rebuild than fat is to lose, and reduced activity during treatment may accelerate that muscle loss rather than offset it, which can affect strength and mobility over time